
It provoked criticism when the majority stakeholder in pharmaceutical firm Lundbeck, the Lundbeck Foundation, proposed a new share structure entailing shares with weaker voting rights than others. Opponents said this would dilute shares without the majority owner having to relinquish any power.
In an interview with Danish media Finans, CEO at the Lundbeck Foundation Lene Skole rejects this notion:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app